Letters Gender dysphoria

What are the risks of oestrogens in women assigned male at birth and how should they be monitored?

BMJ 2017; 358 doi: https://doi.org/10.1136/bmj.j4166 (Published 11 September 2017) Cite this as: BMJ 2017;358:j4166
  1. Jacq Hawkins, general practitioner
  1. Central Lakes Medical Practice, Ambleside LA22 9BP, UK
  1. jlavender62{at}gmail.com

As a general practitioner, I am uncertain about hormonal treatment and its monitoring in patients with gender dysphoria. Barrett mentions that women who were assigned male at birth do not need screening mammography because their risk of breast cancer is very low as their hormonal treatment does not include progestogens.1 What are the other risks …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe